Angiogenin (ANG)—Ribonuclease Inhibitor (RNH1) System in Protein Synthesis and Disease

Sarangdhar, Mayuresh Anant; Allam, Ramanjaneyulu (2021). Angiogenin (ANG)—Ribonuclease Inhibitor (RNH1) System in Protein Synthesis and Disease. International journal of molecular sciences, 22(3), p. 1287. MDPI 10.3390/ijms22031287

[img]
Preview
 Text
ijms-22-01287-v2.pdf - Published Version
Available under License Creative Commons: Attribution (CC-BY).
Download (1MB) | Preview

Item Type:

 Journal Article (Review Article)

Division/Institute:

 04 Faculty of Medicine > Department of Haematology, Oncology, Infectious Diseases, Laboratory Medicine and Hospital Pharmacy (DOLS) > Clinic of Haematology and Central Haematological Laboratory
04 Faculty of Medicine > Pre-clinic Human Medicine > BioMedical Research (DBMR) > Unit Childrens Hospital > Forschungsgruppe Hämatologie (Erwachsene)
04 Faculty of Medicine > Pre-clinic Human Medicine > BioMedical Research (DBMR) > DBMR Forschung Mu35 > Forschungsgruppe Hämatologie / Onkologie (Pädiatrie)
04 Faculty of Medicine > Pre-clinic Human Medicine > BioMedical Research (DBMR) > DBMR Forschung Mu35 > Forschungsgruppe Hämatologie / Onkologie (Pädiatrie)

UniBE Contributor:

 Sarangdhar, Mayuresh Anant, Allam, Ramanjaneyulu

Subjects:

 600 Technology > 610 Medicine & health

ISSN:

 1422-0067

Publisher:

 MDPI

Language:

 English

Submitter:

 Ramanjaneyulu Allam

Date Deposited:

 05 May 2022 10:14

Last Modified:

 05 Dec 2022 15:51

Publisher DOI:

 10.3390/ijms22031287

PubMed ID:

 33525475

BORIS DOI:

 10.48350/157242

URI:

 https://boris.unibe.ch/id/eprint/157242

Actions (login required)

Edit item Edit item
Provide Feedback